Cargando…

The LINC01119-SOCS5 axis as a critical theranostic in triple-negative breast cancer

The development of triple-negative breast cancer (TNBC) is critically regulated by certain tumor-microenvironment-associated cells called mesenchymal stem/stromal cells (MSCs), which we and others have shown promote TNBC progression by activating pro-malignant signaling in neighboring cancer cells....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Zhenbo, Schmoellerl, Johannes, Mariani, Odette, Zheng, Yurong, Hu, Yi, Vincent-Salomon, Anne, Karnoub, Antoine E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166834/ https://www.ncbi.nlm.nih.gov/pubmed/34059683 http://dx.doi.org/10.1038/s41523-021-00259-z

Ejemplares similares

LINC01119 negatively regulates osteogenic differentiation of mesenchymal stem cells via the Wnt pathway by targeting FZD4
por: Gao, Hongwei, et al.
Publicado: (2022)

Long Non-coding RNA LINC01119 Promotes Neuropathic Pain by Stabilizing BDNF Transcript
por: Zhang, Le, et al.
Publicado: (2021)

Long noncoding RNA–mediated activation of PROTOR1/PRR5-AKT signaling shunt downstream of PI3K in triple-negative breast cancer
por: Tu, Zhenbo, et al.
Publicado: (2022)

In vivo gain-of-function cDNA library screening for colonization genes in a mouse model of pulmonary metastasis
por: Tu, Zhenbo, et al.
Publicado: (2022)

Theranostics for Triple-Negative Breast Cancer
por: Choi, Hyeryeon, et al.
Publicado: (2023)

In vivo library screening identifies the metabolic enzyme aldolase A as a promoter of metastatic lung colonization
por: Tu, Zhenbo, et al.
Publicado: (2021)

LINC00167 Regulates RPE Differentiation by Targeting the miR-203a-3p/SOCS3 Axis
por: Chen, Xue, et al.
Publicado: (2020)

Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer
por: Choi, Moon Jung, et al.
Publicado: (2023)

Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer
por: Wen, Huang, et al.
Publicado: (2023)

SIPA1 Regulates LINC01615 to Promote Metastasis in Triple-Negative Breast Cancer
por: Xiang, Yuan, et al.
Publicado: (2022)

Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm
por: Zhang, Min Yue, et al.
Publicado: (2013)

ICAM1-Targeting Theranostic Nanoparticles for Magnetic Resonance Imaging and Therapy of Triple-Negative Breast Cancer
por: Chen, Jieying, et al.
Publicado: (2022)

FOXC1-induced LINC01123 acts as a mediator in triple negative breast cancer
por: Zhang, Purong, et al.
Publicado: (2020)

SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model
por: Kim, Gwangil, et al.
Publicado: (2014)

Preclinical evaluation of an (111)In/(225)Ac theranostic targeting transformed MUC1 for triple negative breast cancer
por: Kelly, Vanessa J, et al.
Publicado: (2020)

LINC01605 promotes aerobic glycolysis through lactate dehydrogenase A in triple‐negative breast cancer
por: Wang, Wei, et al.
Publicado: (2022)

LINC00669 insulates the JAK/STAT suppressor SOCS1 to promote nasopharyngeal cancer cell proliferation and invasion
por: Qing, Xiang, et al.
Publicado: (2020)

Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates
por: Bertoli, Gloria, et al.
Publicado: (2021)

Effects of valproic acid on SOCS-1, SOCS-2, SOCS-3, SOCS-5, SOCS6, and SOCS-7 gene expression and cell growth inhibition in colon carcinoma
por: Sanaei, Masumeh, et al.
Publicado: (2022)

On the Evaluation of SEU Effects on AXI Interconnect Within AP-SoCs
por: De Sio, Corrado, et al.
Publicado: (2020)

The Iron-Inflammation Axis in Early-Stage Triple-Negative Breast Cancer
por: Duan, Fangfang, et al.
Publicado: (2022)

Negative regulation of cytokine signaling and immune responses by SOCS proteins
por: Yoshimura, Akihiko, et al.
Publicado: (2005)

Long noncoding RNA LINC00511 promotes cell growth and invasion in triple-negative breast cancer by interacting with Snail
por: Liu, Ruilei, et al.
Publicado: (2019)

Editorial: Recent advances in the design of novel polymer nanoagents for cancer theranostics
por: Ou, Hanlin, et al.
Publicado: (2023)

Lysyl Oxidase at the Crossroads of Mesenchymal Stem Cells and Epithelial-Mesenchymal Transition
por: Thomas, Clémence, et al.
Publicado: (2013)

STAT3/SOCS3 axis contributes to the outcome of salmonid whirling disease
por: Saleh, Mona, et al.
Publicado: (2020)

Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer
por: Apaya, Maria Karmella, et al.
Publicado: (2019)

Long Noncoding RNA LINC00511 Promotes Cell Growth And Invasion In Triple-Negative Breast Cancer By Interacting With Snail [Retraction]
Publicado: (2019)

Inhibition of miR-483-5p improves the proliferation, invasion and inflammatory response of triple-negative breast cancer cells by targeting SOCS3
por: Ren, Jianbo, et al.
Publicado: (2021)

Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis
por: Zhang, Jie, et al.
Publicado: (2022)

Targeting Cancer Stem Cells—A Renewed Therapeutic Paradigm
por: Amey, Catherine L, et al.
Publicado: (2017)

Alterations in the p53-SOCS2 axis contribute to tumor growth in colon cancer
por: Kim, Jong-Hwan, et al.
Publicado: (2018)

The JAK1/STAT3/SOCS3 axis in bone development, physiology, and pathology
por: Sims, Natalie A.
Publicado: (2020)

Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer
por: Kim, Min Woo, et al.
Publicado: (2019)

Theranostic Attributes of Acoustic Cluster Therapy and Its Use for Enhancing the Effectiveness of Liposomal Doxorubicin Treatment of Human Triple Negative Breast Cancer in Mice
por: Bush, Nigel, et al.
Publicado: (2020)

USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer
por: Ma, Teng, et al.
Publicado: (2020)

Novel Breast-Specific Long Non-coding RNA LINC00993 Acts as a Tumor Suppressor in Triple-Negative Breast Cancer
por: Guo, Shipeng, et al.
Publicado: (2019)

Long non-coding RNA LINC01559 serves as a competing endogenous RNA accelerating triple-negative breast cancer progression
por: Yang, Xue, et al.
Publicado: (2022)

Exploring the oncogenic roles of LINC00857 in pan-cancer
por: Ren, Xiaomin, et al.
Publicado: (2022)

Expression of SHP-1 and SOCS6 in patients with acute leukemia and their clinical implication
por: Liu, Jinmei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i00j31en1aga8aas19f9hollp7